PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Możliwości usuwania środków cieniujących ze ścieków

Treść / Zawartość
Identyfikatory
Warianty tytułu
EN
Possibilities for removal of contrast agents from wastewater
Języki publikacji
PL
Abstrakty
PL
Badania naukowe wskazują na obecność w ściekach związków cieniujących, które w diagnostyce medycznej wykorzystywane są do wizualizacji zmian w tkankach miękkich. Wykazano, że niezmetabolizowane leki, a także produkty ich przemian metabolicznych, trafiają do miejskiej sieci kanalizacyjnej, a następnie do oczyszczalni ścieków. W konwencjonalnych procesach oczyszczania środki cieniujące nie ulegają pełnej mineralizacji i wraz ze ściekami oczyszczonymi przedostają się do wód powierzchniowych. Wykazano, że największą skuteczność usuwania substancji cieniujących (powyżej 80%) uzyskuje się w zaawansowanych procesach utleniania (O3/H2O2, reakcja Fentona, TiO2/H2O2). Skuteczność usuwania tych substancji w procesie osadu czynnego jest mniejsza niż w przypadku zaawansowanego utleniania i wynosi 40÷80%. Ponieważ żadna z obecnie wykorzystywanych technik oczyszczania ścieków nie jest w stanie usunąć wszystkich zanieczyszczeń farmaceutycznych, dlatego poszukuje się nowych rozwiązań (biologicznie produkowane tlenki manganu BioMnOx czy nanocząstki palladu Bio-Pd) oraz łączy się metody fizyczno-chemiczne i biologiczne w celu skuteczniejszego usuwania farmaceutyków ze ścieków.
EN
Scientific studies indicate presence of contrast agents, used for X-ray imaging of soft tissues, in wastewater. Unmetabolized drugs as well as their metabolites enter municipal sewage system and then are discharged into the wastewater treatment plant. Contrast agents are not fully mineralized in conventional treatment processes and enter surface waters with treated wastewater. It was demonstrated that the highest efficacy of contrast media removal (above 80%) was obtained in advanced oxidation processes (AOPs: O3/H2O2, Fenton’s reaction, TiO2/H2O2). The efficacy of contrast media removal using the activated sludge process is lower than in AOPs and ranges from 40 to 80%. As none of the treatment techniques currently used is sufficient to eliminate all the pharmaceutical contaminants, new solutions are tested (biologically produced nanoparticles of manganese oxide, BioMnOx or palladium, Bio-Pd) and a combined approach of physicochemical and biological methods for the effective removal of pharmaceuticals from wastewater is taken into consideration.
Czasopismo
Rocznik
Strony
55--63
Opis fizyczny
Bibliogr. 80 poz., tab., wykr.
Twórcy
autor
  • Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki, ul. Akademicka 2, 44-100 Gliwice
autor
  • Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki, ul. Akademicka 2, 44-100 Gliwice
  • Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki, ul. Akademicka 2, 44-100 Gliwice
Bibliografia
  • 1. T. TERNES, M. STUMPF, B. SCHUPPERT, K. HEBERER: Simultaneous determination of antiseptics and acidic drugs in sewage and river water. Vom Wasser 1998, No. 90, pp. 295–309.
  • 2. S. PÉREZ, D. BARCELÓ: Fate and occurrence of X-ray contrast media in the environment. Analytical and Bioanalytical Chemistry 2007, Vol. 387, No. 4, pp. 1235–1246.
  • 3. E. FELIS, K. MIKSCH, J. SURMACZ-GÓRSKA, T.A. TERNES: Presence of pharmaceutics in wastewater from waste water treatment plant Zabrze-Śródmieście in Poland. Archives of Environmental Protection 2005, Vol. 31, No. 3, pp. 49–58.
  • 4. T. STEGER-HARTMANN, R. LÄNGE, H. SCHWEINFURTH, M. TSCHAMPEL, I. REHMANN: Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium. Water Research 2002, Vol. 36, No. 1, pp. 266–274.
  • 5. E.M. CHELLQUIST, W.O. NELSON, H.L. STORFLOR: Assay and purity analysis of diatrizoate sodium in drug product by LC. Journal of Pharmaceutical and Biomedical Analysis 1997, Vol.16, No.1, pp. 39–45.
  • 6. K. KÜMMERER, M. HEMPEL: Green and Sustainable Pharmacy. Springer, Berlin-Heidelberg 2010.
  • 7. K. KÜMMERER: Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Springer, Berlin–Heidelberg 2001.
  • 8. Dyrektywa 2001/83/WE Parlamentu Europejskiego i Rady z 6 listopada 2001 r. w sprawie wspólnotowego kodeksu odnoszącego się do produktów leczniczych stosowanych u ludzi. Dz. U. L 311 z 28-11-2001, s. 67.
  • 9. G. NAŁĘCZ-JAWECKI: Farmaceutyki – nowe zanieczyszczenie środowiska. Przegląd Komunalny 2007, nr 9, ss. 20–22.
  • 10. K. FENT, A.A. WESTON, D. CAMINADA: Ecotoxicology of human pharmaceuticals. Aquatic Toxicology 2006, No. 76, pp. 122–159.
  • 11. M.L. RICHARDSON, J.M. BOWRON: The fate of pharmaceutical chemicals in the aquatic environment. Journal of Pharmacy and Pharmacology 1985, No. 37, pp. 1–12.
  • 12. I.H. ROGERS, I.K. BIRTWELL, G.M. KRUZNYSKI: Organic extractables in municipal wastewater of Vancouver, British Columbia. Water Pollution Research Journal of Canada 1986, No. 21, pp. 187–204.
  • 13. D. BUNTNER, S. ŻABCZYŃSKI, K. MIKSCH: Usuwanie farmaceutyków ze ścieków. Chemik 2007, vol. 60, nr 2, ss. 120–124.
  • 14. KNAPPE Final Report (http://environmentalhealthcollaborative.org/images/KNAPPE_REPORT_FINAL.pdf), 22-01-2014.
  • 15. R. DUSAJ, J.S. REINER: Iodinated contrast media – a safety review. Interventional Cardiology Review 2009, Vol. 4, No. 1, pp. 22–25.
  • 16. C. CHRISTIANSEN: X-ray contrast media – an overview. Toxicology 2005, Vol. 209, No. 2, pp.185–187.
  • 17. W. KRAUSE, P.W. SCHNEIDER: Chemistry of X-Ray contrast agents. Topics in Current Chemistry 2002, Vol. 222, pp. 107–150.
  • 18. F. STACUL: Current iodinated contrast media. European Radiology 2001, Vol. 11, No. 4, pp. 690–697.
  • 19. J. SINGH, A. DAFTARY: Iodinated contrast media and their adverse reactions. Journal of Nuclear Medicine Technology 2008, Vol. 36, No. 2, pp. 69–74.
  • 20. The DrugBank database (www.drugbank.ca), 22-01-2014.
  • 21. T. HEBERER: Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters 2002, Vol. 131, No. 1–2, pp. 5–17.
  • 22. T.E. DOLL, F.H. FRIMMEL: Removal of selected persistent organic pollutants by heterogeneous photocatalysis in water. Catalysis Today 2005, Vol. 101, No. 3–4, pp. 195–202.
  • 23. M. SCHULZ, D. LÖFFLER, M. WAGNER, T.A. TERNES: Transformation of the X-ray contrast medium iopromide in soil and biological wastewater treatment. Environmental Science Technology 2008, Vol. 42, No. 19, pp. 7207–7217.
  • 24. A. HAISS, K. KÜMMERER, Biodegradability of the X-ray contrast compound diatrizoic acid, identification of aerobic degradation products and effects against sewage sludge microorganisms. Chemosphere 2006, Vol. 62, No. 2, pp. 294–302.
  • 25. A. PUTSCHEW, S. WISCHNACK, M. JEKEL: Occurrence of triiodinated X-ray contrast agents in the aquatic environment. The Science of the Total Environment 2000, Vol. 255, No. 1, pp. 129–134.
  • 26. A. NIKOLAOU, S. MERIC, D. FATTA: Occurrence patterns of pharmaceuticals in water and wastewater environments. Analytical and Bioanalytical Chemistry 2007, Vol. 387, No. 4, pp.1225–1234.
  • 27. B. PAUWELS, W. VERSTRAETE: The treatment of hospital wastewater: An appraisal. Journal of Water and Health 2006, Vol. 4, No. 4, pp. 405–416.
  • 28. P. VERLICCHI, A. GALLETTI, M. PETROVIC, D. BARCELÓ: Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. Journal of Hydrology 2010, Vol. 389, No. 3–4, pp. 416–428.
  • 29. S. GARTISER, L. BRINKER, T. ERBE, K. KÜMMERER, R. WILLMUND: Contamination of hospital wastewater with hazardous compounds as defined by 7a WHG. Acta Hydrochimica et Hydrobiologica 1996, Vol. 24, No. 2, pp. 90–97.
  • 30. E. EMMANUEL, Y. PERRODIN, G. KECK, J.M. BLAN-CHARD, P. VERMANDE: Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. Journal of Hazar-dous Materials 2005, Vol. 117, No. 1, pp. 1–11.
  • 31. K. KÜMMERER, T. ERBE, S. GARTISER, L. BRINKER: AOX – emissions from hospitals into municipal waste water. Chemosphere 1998, Vol. 36, No. 11, pp. 2437–2445.
  • 32. J. KNODEL, S.U. GEISSEN, J. BROLL, U. DÜNNBIER: Simulation and source identification of X-ray contrast media in the water cycle of Berlin. Journal of Environmental Management 2011, Vol. 92, No. 11, pp. 2913–2923.
  • 33. M.M. HUBER, A. GÖBEL, A. JOSS, N. HERMANN, D. LÖFFLER, C.S. MCARDELL, A. RIED, H. SIEGRIST, T.A. TERNES, U. von GUTEN: Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: A pilot study. Environmental Science Technology 2005, Vol. 39, No. 11, pp. 4290–4299.
  • 34. J. JEONG, J. JUNG, W.J. COOPER, W. SONG: Degradation mechanisms and kinetic studies for the treatment of X-ray contrast media compounds by advanced oxidation/reduction processes. Water Research 2010, Vol. 44, No. 15, pp. 4391–3498.
  • 35. T.A. TERNES, J. STÜBER, N. HERRMANN, D. MCDOWELL, A. RIED, M. KAMPMANN, B. TEISER: Ozonation: A tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Research 2003, Vol. 37, No. 8, pp. 1976–1982.
  • 36. P. XU, M.L. JANEX, P. SAVOYE, A. COCKX, V. LAZAROVA: Wastewater disinfection by ozone: main parameters for process design. Water Research 2002, Vol. 36, No. 4, pp. 1043–1055.
  • 37. C. COMNINELLIS, A. KAPALKA, S. MALATO, S.A. PARSONS, I. POULIOS, D. MANTZAVINOS: Advanced oxidation processes for water treatment: Advances and trends for R&D. Journal of Chemical Technology and Biotechnology 2008, Vol. 83, No. 6, pp. 769–776.
  • 38. K. IKEHATA, N.J. NAGHASHKAR, M.G. EL-DIN: Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review. Ozone: Science and Engineering: The Journal of the International Ozone Association 2007, Vol. 28, No. 6, pp. 353–414.
  • 39. T. NÖTHE, H. FAHLENKAMP, C. von SONNTAG: Ozonation of wastewater: Rate of ozone consumption and hydroxyl radical yield. Environmental Science and Technology 2009, Vol. 43, No. 15, pp. 5990–5995.
  • 40. T.A. LARSEN, J. LIENERT, A. JOSS, H. SIEGRIST: How to avoid pharmaceuticals in the aquatic environment. Journal of Biotechnology 2004, Vol. 113, No. 1–3, pp. 295–304.
  • 41. W. SEITZ, J.Q. JIANG, W. SCHULZ, W.H. WEBER, D. MAIER, M. MAIER: Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation. Chemosphere 2008, Vol. 70, No. 7, pp. 1238–1246.
  • 42. S. ESPLUGAS, D.M. BILA, L.G.T. KRAUSE, M. DEZOTTI: Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. Journal of Hazardous Materials 2007, Vol. 149, No. 3, pp. 631–642.
  • 43. F. WANG, D.W. SMITH, M.G. EL-DIN: Application of advanced oxidation methods for landfill leachate treatment – a review. Journal of Environmental Engineering and Science 2003, Vol. 2, No. 6, pp. 413–427.
  • 44. T.E. AGUSTINA, H.M. ANG, V.K. VAREEK: A review of synergistic effect of photocatalysis and ozonation on wastewater treatment. Journal of Photochemistry and Photobiology C: Photochemistry Reviews 2005, Vol. 6, No. 4, pp. 264–273.
  • 45. A. CESARO, V. NADDEO, V. BELGIORNO: Wastewater treatment by combination of advanced oxidation processes and conventional biological systems. Bioremediation and Biodegradation 2013, Vol. 4, No. 8, pp. 1–8.
  • 46. O. LEGRINI, E. OLIVEROS, A.M. BRAUN: Photochemical processes for water treatment. Chemical Reviews 1993, Vol. 93, No. 2, pp. 671–698.
  • 47. M.P. FASNACHT, N.V. BLOUGH: Aqueous photodegradation of polycyclic aromatic hydrocarbons. Environmental Science and Technology 2002, Vol. 36, No. 20, pp. 4364–4369.
  • 48. J.-M. HERRMANN: Heterogeneous photocatalysis: Fundamentals and applications to the removal of various types of aqueous pollutants. Catalysis Today 1999, Vol. 53, No. 1, pp. 115–129.
  • 49. E. ADAMEK, J. JAKUBCZYK, W. BARAN, A. MAKOWSKI, I. LIPSKA, J. ZIEMIAŃSKA, A. SOBCZAK: Fotodegradacja wybranych leków przeciwzapalnych w środowisku wodnym. Proceedings of ECOpole 2011, vol. 5, nr 1, ss. 147–153.
  • 50. M.A. LAZAR, S. VARGHESE, S.S. NAIR: Photocatalytic water treatment by titanium dioxide: Recent updates. Catalysts 2012, Vol. 2, pp. 572–601.
  • 51. O. CARPA, C.L. HUISMANB, A. RELLERB: Photoinduced reactivity of titanium dioxide. Progress in Solid State Chemistry 2004, Vol. 32, No. 1–2, pp. 33–177.
  • 52. C. PABLOS, J. MARUGAN, R.V. GRIEKEN, E. SERRANO: Emerging micropollutant oxidation during disinfection processes using UV-C, UV-C/H2O2, UV-A/TiO2 and UV-A/TiO2/H2O2. Water Research 2013, Vol. 47, No. 3, pp. 1237–1245.
  • 53. O. AUTIN, J. HART, P. JARVIS, J. MACADAM, S.A. PARSONS, B. JEFFERSON: Comparison of UV/H2O2 and UV/TiO2 for the degradation of metaldehyde: Kinetics and the impact of background organics. Water Research 2012, Vol. 46, No. 17, pp. 5655–5662.
  • 54. T.W. CHAN, N.J GRAHAM, W. CHU: Degradation of iopromide by combined UV irradiation and peroxydisulfate. Journal of Hazardous Materials 2010, Vol. 181, No. 1–3, pp. 508–513.
  • 55. C. COMNINELLIS, A. KAPALKA, S. MALATO, S.A PARSONS, I. POULIOS, D. MANTZAVINOS: Perspective advanced oxidation processes for water treatment: advances and trends for R&D. Journal of Chemical Technology and Biotechnology 2008, Vol. 83, No. 6, pp. 769–776.
  • 56. J. YOON, Y. LEE, S. KIM: Investigation of the reaction pathway of OH radicals produced by Fenton oxidation in the conditions of wastewater treatment. Water Science and Technology 2001, Vol. 44, No. 5, pp. 15–21.
  • 57. E. NEYENS, J. BAEYENS: A review of classic Fenton’s peroxidation as an advanced oxidation technique. Journal of Hazardous Materials 2003, Vol. 98, No. 1–3, pp. 33–50.
  • 58. J. WĄSOWSKI, A. PIOTRKOWSKA: Rozkład organicznych zanieczyszczeń wody w procesach pogłębionego utleniania. Ochrona Środowiska 2002, vol. 85, nr 2, ss. 27–32.
  • 59. K. BARBUSIŃSKI: Fenton reaction – controversy concerning the chemistry. Ecological Chemistry and Engineering S 2009, Vol. 16, No. 3, pp. 347–358.
  • 60. M.Y. XING, D. CAN, B. GODEFROID, J. YANG: Treatment of pharmaceutical wastewater containing recalcitrant compounds in a Fenton-coagulation process. Journal of Environmental Sciences (China) 2006, Vol. 18, No. 3, pp. 459–463.
  • 61. H. TEKIN, O. BILKAY, S.S. ATABERK, T.H. BALTA, I.H. CERIBASI, F.D. SANIN, F.B. DILEK, U. YETIS: Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater. Journal of Hazardous Materials 2006, Vol. 136, No. 2, pp. 258–265.
  • 62. M.A. TARR: Fenton and modified Fenton methods for pollutant degradation. Environmental Science and Pollution Control Series 2003, pp. 165–200.
  • 63. R. ANDREOZZI, V. CAPRIO, A. INSOLA, R. MAROTTA: Advanced oxidation processes (AOP) for water purification and recovery. Catalysis Today 1999, Vol. 53, No. 1, pp. 51–59.
  • 64. T. RASTOGI, C. LEDER, K. KUEMMER: Qualitative environmental risk assessment of photolytic transformation products of iodinated X-ray contrast agent diatrizoic acid. Science of the Total Environment 2014, Vol. 482–483, pp.378–388.
  • 65. W. SEITZ, W.H. WEBER, J.-Q. JIANG, B.J. LLOYD, M. MAIER, D. MAIER, W. SCHULZ: Monitoring of iodinated X-ray contrast media in surface water. Chemosphere 2006, Vol. 64, No. 8, pp. 1318–1324.
  • 66. W. KALSCH: Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide. Science of the Total Environment 1999, Vol. 225, No. 1–2, pp. 143–153.
  • 67. B. NING, N.J. GRAHAM, P.D. LICKISS: Degradation of X-Ray contrast media compounds by combined ozone and ultrasound. Water Environment Research 2007, Vol. 79, No. 12, pp. 2427–2436.
  • 68. M. CARBALLA, F. OMIL, J.M. LEMA, M. LOMPART, C. GARCÍA-JARES, I. RODRÍGUEZ, M. GÓMEZ, T.A. TERNES: Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research 2004, Vol. 38, No. 12, pp. 2918–2926.
  • 69. H. STEINMETZ, J. WIESE, T.G. SCHMITT: Efficiency of SBR technology in municipal wastewater treatment plants. Water Science and Technology 2002, Vol. 46, No. 4–5, pp. 293–299.
  • 70. E. FELIS, K. MIKSCH, J. SIKORA: Występowanie i możliwości usuwania farmaceutyków w Polsce, Mat. VII ogólnopolskiej sesji popularnonaukowej „Środowisko a zdrowie – 2005”, IETU, Katowice 2005.
  • 71. S. ŻABCZYŃSKI, E. FELIS, J. SURMACZ-GÓRSKA, K. MIKSCH, T.A. TERNES: Fate of PPCPs in sequencing batch reactor (SBR). Architecture Civil Engineering Environment 2009, Vol. 2, No. 3, pp. 127–132.
  • 72. S. JUDD: The MBR Book: Principles and Applications of Membrane Bioreactors for Water and Wastewater Treatment. Elsevier, Oxford 2011.
  • 73. J. SIPMA, B. OSUNA, N. COLLADO, H. MONCLÚS, G. FERRERO, J. COMAS, I. RODRIGUEZ-RODA: Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 2010, Vol. 250, No. 2, pp. 653–659.
  • 74. M. CLARA, B. STRENN, O. GANS, E. MARTINEZ, N. KREUZINGER, H. KROISS: Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Research 2005, Vol. 39, pp. 4797–4807.
  • 75. M. BODZEK, K. KONIECZNY: Wykorzystanie technik membranowych w uzdatnianiu wody do picia. Cz. I. Usuwanie związków nieorganicznych. Technologia Wody 2010, vol. 1, nr 3, ss. 9–21.
  • 76. J. RADJENOVIC, M. PETROVIC, D. BARCELÓ: Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Analytical and Bioanalytical Chemistry 2007, Vol. 387, No. 4, pp.1365–1377.
  • 77. L. KOVALOVA, H. SIEGRIST, H. SINGER, A. WITTMER, C.S. MCARDELL: Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environmental Science and Technology 2012, Vol. 46, No. 3, pp. 1536–1545.
  • 78. S. ŻABCZYŃSKI, R. BUCZYŃSKI, A. ZIEMBIŃSKA: X-ray contrast media removal in membrane bioreactors, Low Carbon Earth Summit 2011. BIT’s 1st World Congress of Environmental Biotechnology, China 2011, p. 105.
  • 79. I. FORREZ, M. CARBALLA, G. FINK, A. WICK, T. HENNEBEL, L. VANHAECKE, T.A. TERNES, N. BOON, W. VERSTRAETE: Biogenic metals for the oxidative and reductive removal of pharmaceuticals, biocides and iodinated contrast media in a polishing membrane bioreactor. Water Research 2011, Vol. 45, No. 4, pp. 1763–1773.
  • 80. T. HENNEBEL, S. de CORTE, L. VANHAECKE, K. VANHERCK, I. FORREZ, B. de GUSSEME, P. VERHAGEN, K. VERBEKEN, B. van der BRUGGEN, I. VANKELECOM, N. BOON, W. VERSTRAETE: Removal of diatrizoate with catalytically active membranes incorporating microbially produced palladium nanoparticles. Water Research 2010, Vol. 44, No. 5, pp. 1498–1506.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-c4643c36-e097-46ef-96f2-8a30900cd2f7
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.